Correction of Nasolabial Folds Clinical Trial
Official title:
A Prospective, Open Label, Multicenter, Post Market Study Evaluating Princess® FILLER Lidocaine for the Correction of Nasolabial Folds
In this study, eligible subjects with moderate to severe nasolabial folds will be treated with Princess® FILLER Lidocaine and will return for follow-up assessments 2, 4, 24 and 36 weeks after the treatment. A Touch-up treatment may be done at Week 2, if deemed appropriate by the investigator
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02334358 -
Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s
|
||
| Completed |
NCT05106751 -
A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds
|
Phase 4 | |
| Completed |
NCT02661737 -
Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
|
||
| Completed |
NCT02179606 -
Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus
|
Phase 3 | |
| Completed |
NCT03650218 -
Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds
|
N/A | |
| Completed |
NCT05235126 -
A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF)
|
N/A | |
| Completed |
NCT02179619 -
Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds
|
Phase 3 | |
| Unknown status |
NCT01492140 -
Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers
|
Phase 4 |